© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Ernest L. Mazzaferri, MD, MACP
Articles
What Is the Optimal Initial Treatment of Low-Risk Papillary Thyroid Cancer (and Why Is It Controversial)?
June 11, 2009
ByErnest L. Mazzaferri, MD, MACPPatients with papillary thyroid cancer typically undergo a triad of consecutive initial treatments, comprising surgery, radioiodine therapy, and thyroid hormone suppression of serum thyrotropin (thyroid-stimulating hormone, or TSH).